Apolipoprotein E (apoE) has been recently implicated in the pathogenesis of Alzheimer's disease (A.D.) One of the apoE alleles, epsilon4, behaves as an autosomal co-dominant trait in the majority of late-onset and sporadic A.D.. The apoE4 gene dose is a major risk-factor susceptibility gene for A.D. with homozygosity for this allele virtually sufficient to cause disease by age 80, and with 50% of homozygous patients developing disease by age 68. In contrast, the epsilon2 and epsilon3 alleles decrease the probability of disease, and increase the age of onset, with the protective effect of epsilon2 greater than epsilon3. Thus the inherited apoE allele determines in part, the risk of developing Alzheimer disease, and determines the rate of disease progression. Interactions of apoE protein with other molecules is therefore critical int he disease process, with isoform-specific interactions of apoE determining the probability,a nd rate, of disease expression. The three common protein isoforms of apoE; E2, E3, E4, differ from each other by one amino acid, which determines their profoundly differing interactions with other proteins. In vitro, apoE4 binds betaA peptide (the primary constituent of the neuritic plaque) faster, and with a different pH dependence, than does aplE3. This isoform-specific difference observed in vitro correlates with the greater betaA peptide amyloid burden deposited in situ in homozygous epsilon4 A.D. patients, compared with homozygous epsilon3 A.D. patients. Paired-helical filaments of the neurofibrillary tangle are composed of tau protein. ApoE3 avidly binds tau in vitro, forming a complex not dissociated by boiling in SDS. In contrast, apoE4 does not form such a complex. Isoform-specific interactions of apoE with tau cold alter tau function or metabolism. ApoE is found in populations of neurons, some of which contain neurofibrillary tangles. In vitro interactions of the apoE isoforms have been studied only semi- quantitatively under harshly denaturing conditions. The technique of surface plasmon resonance will be employed to characterize interactions of the apoE isoforms with other molecules quantitatively and under physiologic conditions. This technique permits the characterization of protein interactions including affinity measurements to 10-6M sec-1. No derivitization of the proteins is required, and the sensitivity of detection is picomolar. Quantitative characterization of isoform-specific interactions of apoE with other molecules under physiologic conditions is essential to identify molecular targets by which apoE is relevant to A.D.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
2P50AG005128-12
Application #
3726235
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
12
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Duke University
Department
Type
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Petyuk, Vladislav A; Chang, Rui; Ramirez-Restrepo, Manuel et al. (2018) The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease target. Brain 141:2721-2739
Sims, Rebecca (see original citation for additional authors) (2017) Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nat Genet 49:1373-1384
Jun, Gyungah R; Chung, Jaeyoon; Mez, Jesse et al. (2017) Transethnic genome-wide scan identifies novel Alzheimer's disease loci. Alzheimers Dement 13:727-738
Hohman, Timothy J; Bush, William S; Jiang, Lan et al. (2016) Discovery of gene-gene interactions across multiple independent data sets of late onset Alzheimer disease from the Alzheimer Disease Genetics Consortium. Neurobiol Aging 38:141-150
Jun, G; Ibrahim-Verbaas, C A; Vronskaya, M et al. (2016) A novel Alzheimer disease locus located near the gene encoding tau protein. Mol Psychiatry 21:108-17
Hohman, Timothy J; Cooke-Bailey, Jessica N; Reitz, Christiane et al. (2016) Global and local ancestry in African-Americans: Implications for Alzheimer's disease risk. Alzheimers Dement 12:233-43
Karch, Celeste M; Ezerskiy, Lubov A; Bertelsen, Sarah et al. (2016) Alzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci. PLoS One 11:e0148717
Mez, Jesse; Mukherjee, Shubhabrata; Thornton, Timothy et al. (2016) The executive prominent/memory prominent spectrum in Alzheimer's disease is highly heritable. Neurobiol Aging 41:115-121
Ridge, Perry G; Hoyt, Kaitlyn B; Boehme, Kevin et al. (2016) Assessment of the genetic variance of late-onset Alzheimer's disease. Neurobiol Aging 41:200.e13-200.e20
Ghani, Mahdi; Reitz, Christiane; Cheng, Rong et al. (2015) Association of Long Runs of Homozygosity With Alzheimer Disease Among African American Individuals. JAMA Neurol 72:1313-23

Showing the most recent 10 out of 97 publications